Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome

• Reinhard Stöger ,

  * E-mail: reinhard.stoger@nottingham.ac.uk (RS); cdlaird@u.washington.edu (CL)

  Affiliations Department of Biology, University of Washington, Seattle, Washington, United States of America, School of Biosciences, University of Nottingham, Leicestershire, United Kingdom

  ⨯
• Diane P. Genereux,

  Affiliation Department of Biology, University of Washington, Seattle, Washington, United States of America

  ⨯
• Randi J. Hagerman,

  Affiliations Medical Investigation of Neurodevelopmental Disorders Institute, University of California Davis Medical Center, Sacramento, California, United States of America, Department of Pediatrics, School of Medicine, University of California Davis, Davis, California, United States of America

  ⨯
• Paul J. Hagerman,

  Affiliations Medical Investigation of Neurodevelopmental Disorders Institute, University of California Davis Medical Center, Sacramento, California, United States of America, Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, California, United States of America

  ⨯
• Flora Tassone,

  Affiliations Medical Investigation of Neurodevelopmental Disorders Institute, University of California Davis Medical Center, Sacramento, California, United States of America, Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Davis, California, United States of America

  ⨯
• Charles D. Laird

  * E-mail: reinhard.stoger@nottingham.ac.uk (RS); cdlaird@u.washington.edu (CL)

  Affiliations Department of Biology, University of Washington, Seattle, Washington, United States of America, Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America

  ⨯